Cell Wizardry

English

Dr. Uri Alon. Tracing gene circuitry

 

 

 

 

Life is about decision making. From humans down to unicellular organisms it's all about striking the best deal, finding the greenest pastures or, say, choosing the quickest escape route from fire, predators, or noxious chemicals.


At the command post, on a submicron scale, lies the cell. First viewed by the human eye during the late 1600s but sporting billions of years of evolutionary polish, it easily rivals today's most advanced computers. On receiving information about its environment, the cell processes it, filters out irrelevant cues, cross-checks the extracted information with prior experience, and decides upon an appropriate 'output,' or response strategy.


Scientists have spent decades piecing together this picture of the cell's nuts and bolts. Yet its actual circuitry and time-dependent responses to environmental stimuli remain elusive. Pooling together computer science, a research tool derived from an ancient jellyfish defense strategy, and his background in theoretical physics, Dr. Uri Alon of the Weizmann Institute's Molecular Cell Biology Department is tackling these questions. His goal: to trace how gene circuitries and their encoded proteins perform computations within the cell; to find out how the cell 'thinks.'


Alon and his team, including postdoctoral fellow Michal Ronen and Ph.D. student Shiraz Kalir, created an experimental 'tracking' system capable of monitoring the simultaneous expression of multiple genes in real time. Their idea was to take a well-studied molecular pathway, such as the one found in Escherichia coli bacteria, and examine it using green florescent protein (GFP), originally isolated in the jellyfish Aequorea victoria. (See below.)


E. coli divides every 30 minutes when food is plentiful, Alon explains. But when things get rough the bacterium prepares to swim away, using a microscopic protein-based 'engine' complete with paddling flagellar appendages, a 100-rpm 'motor,' and an internal computer that directs the bacterium to food-rich areas by examining concentration gradients. To save energy this motor is produced only upon demand, when food runs low. The transformation from a stationary, dividing bacterium to a mobile E. coli takes three generations, with the cell making the initial parts of an engine that its 'grandchildren' will complete.


Using genetic engineering, Alon introduced the gene for GFP into these bacterial genes so that they glow green when expressed (i.e., when they are engaged in protein production). The result: a live system that can be monitored in real time through sequential snapshots. By developing computer algorithms that cluster this information according to the recording time, the team was then able to map the precise timeline of events controlling the bacterium's 'food-detecting' circuitry. Their study was recently published in Science.


'Scientists spent roughly three decades mapping this bacterial network using classic genetic methods, systematically knocking out gene after gene to determine its function,' says Alon. 'Our approach enabled us to reconstruct the entire system within weeks. We confirmed previous studies but also added something new: There's an exquisite synchrony between the time in which each protein is produced and where it is assembled within the bacterial engine.'


Performing with conveyor-belt precision, the bacterium produces 50 proteins divided into 14 groups. First come information processing proteins, then the intracellular structural components of the 'rotary motor,' and finally the extracellular flagellar components. Timing is key. During the second stage, for instance, seven gene groups turn on sequentially according to the motor assembly order, while the last gene activates the third stage. 'These findings highlight how nature excels at conserving energy through methodical planning,' says Alon. 'There's no point in producing a protein until its forerunner is available.'


Following their success with the E. coli model Alon and his team are moving to new protein networks, including one that switches on following DNA damage, dubbed the SOS repair system. Their immediate goal, however, is to construct a detailed map of the bacterial cell circuitry triggered in response to diverse stimuli. Success at this may vault over bacterial lines, edging toward a Holy Grail of molecular biology: 'The dream is to draw up a blueprint of the human cell, to set up a research infrastructure based on mathematical algorithms that can trace diverse protein circuitries,' says Alon.


Just as engineers use detailed diagrams of their machines to zero in on performance problems, the ability to trace protein pathways - for instance what goes wrong in a specific disease - may lead to highly selective medicines targeting a system's weak link, as well as other creative biotech applications.


Where Submarine Warfare Meets Molecular Genetics
 

The human body contains over 30,000 proteins interacting in dense networks. Figuring out how the cell orchestrates the stuff of life, the way in which it responds to environmental stimuli by playing the DNA like a keyboard to activate certain genes while suppressing others, is a hefty task.


Since 1996, when its three-dimensional structure was solved, green florescent protein (GFP) has lent an increasingly important hand, being used by laboratories across the world to track the expression of proteins in organisms ranging from bacteria and nematodes to rats and humans. It offers unique advantages for the real time exploration of molecules and organelles in live cells.
 

Originally isolated from Aequorea Victoria, a jellyfish commonly found in the Pacific Ocean, GFP protects the animal by teaming up with another protein  aequorin  that is activated by rising calcium levels in response to a perceived threat. Aequorin emits a blue light which is then 'edited' by GFP to produce a bright green flash that presumably scares off the attacker. Ships and submarines also trigger this unique defense mechanism in the jellyfish, resulting in a glowing trail of light that marks the ship's course  which explains the U.S. military's longstanding interest in the jellyfish.

 

 

Dr. Uri Alon holds the Carl and Frances Korn Career Development Chair in the Life Sciences. His research is supported by the Dr. Ernst Nathan Fund for Biomedical Research, the Mrs. Harry M. Ringel Memorial Foundation, the Cherpak-Vered Visiting Fellowship, Yad Hanadiv, and the Minerva Stiftung Gesellschaft fuer die Forschung m.b.H.

 
Dr. Uri Alon.
Life Sciences
English

Curbing the Clock

English

Prof. Abraham Amsterdam. Biological baby clock

 

 

 

 

 

 

 

 

 

 

Sounding in part the shrewd financial investor, in part the philosopher, Prof. Abraham Amsterdam is fascinated by windows of opportunity - from an ovary's perspective, that is.

As more and more women pursue successful careers, many are waiting well into their 30s and some into their 40s to have children. Much of the freedom to do so stems from a profound change in life expectancy rates. In 1880, a woman's average life span was only 45. Today, a Western woman has a fair chance of raising a toast on her 80th birthday and beyond.

New times, new customs. Yet one thing hasn't changed - a woman's biological clock. While a healthy 35-year-old woman is just as likely as a 25-year-old to deliver a normal, healthy baby, her chances of becoming pregnant within the first year of "trying" are roughly 50 percent. This rate plunges to 27 percent for women aged 40 to 44, accompanied by a one-in-three chance of miscarriage.

What controls this biological clock? And how can science be used to curb its relentless beat?

Prof. Abraham Amsterdam of the Weizmann Institute's Molecular Cell Biology Department is probing the cellular cross-talk determining ovarian function. A better understanding of this ticking puzzle might reduce the age-related decline in female fertility and may also yield important fringe benefits, delaying the dramatic increase in ovarian cancer, cardiovascular disease, and osteoporosis that mark the onset of menopause.

"Ovarian cell death is actually an essential process," Amsterdam emphasizes. The mammalian cycle is characterized by a Darwinian race between follicle-enclosed ova. One of the follicles (the dominant follicle) eventually takes the lead and excretes compounds suppressing the development of the other follicles. In spite of a woman having roughly 500,000 eggs before puberty, on average only 480 of these will reach ovulation.

Why must so many eggs be eliminated? "One can describe this as a 'death-for-life' phenomenon," says Amsterdam. "It's essential to eliminate the extra eggs; otherwise the human race would cease to exist, since women cannot normally have multiple-embryo pregnancies."

Interestingly, the process governing ovarian cell death is the same as that which plays a central role in protecting the body against cancer. Known as apoptosis, or programmed cell suicide, it is how the body rids itself of surplus or damaged cells. "Our primary goal is to learn how to fine-tune ovarian cell death," says Amsterdam. "The ability to induce apoptosis may lead to future treatments for ovarian cancer. On the other hand, by suppressing apoptosis we may extend a woman's reproductive years."

 

Motherhood as a Marionette

Achieving this goal - as Amsterdam and others are increasingly discovering - is all about determining ways to maneuver the intricate cross-talk between genes and their protein products. The key is to learn which levers to push - and how. It's much like operating a marionette. The strings of the marionette include hormones, apoptosis-inducing "death genes," and their alter ego, "survival genes." The first steps in this direction have already been taken. Working with doctoral student Ravid Sasson and Dr. Kimihisa Tajima, a visiting physician from Japan, Amsterdam has recently discovered that glucocorticoids (hormones such as cortisol and cortisone) protect ovarian cells from apoptosis. As reported in Endocrinology, the study demonstrated that glucocorticoids have a dual effect. "While they protect ovarian cells from apoptosis, they have the opposite effect on white blood cells taking part in the inflammatory process during menstruation," says Amsterdam.

Like glucocorticoids, Leptin, secreted by adipocytes (fat cells), dramatically reduces ovarian cell death, as well as controlling sex hormone production. Working with doctoral student Dalit Barkan and Prof. Menachem Rubinstein of the Institute's Molecular Genetics Department, Amsterdam found that both leptin and the glucocorticoids exert their effect through a central behind-the-scenes mediator: the Bcl-2 survival gene. He is currently collaborating with physicians at Rehovot's Kaplan Hospital and the Tel Aviv and Sheba Medical Centers to examine the effect of these substances on women undergoing in vitro fertilization.

What about a broader, standard treatment for young women wishing to push the "snooze button" on their biological clocks while they pursue advanced degrees, start a company or travel around the world? "Currently, this remains a distant prospect," says Amsterdam. "Nevertheless, a better understanding of apoptosis in normal ovarian function may yield other benefits, including improved treatments for ovarian pathologies. Recent evidence links impaired apoptosis with polycystic ovaries (which cause infertility) as well as with ovarian cancer - the number one gynecological killer."

Anti- Inflammatory action of Glucocorticoids in the Ovary

Like glucocorticoids, Leptin, secreted by adipocytes (fat cells), dramatically reduces ovarian cell death, as well as controlling sex hormone production. Working with doctoral student Dalit Barkan and Prof. Menachem Rubinstein of the Institute's Molecular Genetics Department, Amsterdam found that both leptin and the glucocorticoids exert their effect though a central behind-the-scenes mediator: the Bcl-2 survival gene. He is currently collaborating with physicians at Rehovot's Kaplan Hospital and the Tel Aviv and Sheba Medical Centers to examine the effect of these substances on women undergoing in vitro fertilization.
 
What about a broader, standard treatment for young women wishing to push the "snooze button" on their biological clocks while they pursue advanced degrees, start a company, or travel around the world? "Currently, this remains a distant prospect," says Amsterdam. "Nevertheless, a better understanding of apoptosis in normal ovarian function may yield other benefits, including improved treatments for ovarian pathologies. Recent evidence links impaired apoptosis with polycystic ovaries (which cause infertility) as well as with ovarian cancer - the number one gynecological killer.
 
Prof. Abraham Amsterdam
Life Sciences
English

The Secrets of Secretion

English

Prof. Jeffrey Gerst, Michael Marash: fundamental life mechanism

 

Let's talk about secretion. This suggestion would probably cause more than a few raised eyebrows - especially if offered by the media. But science writing has its fair share of unusual tasks, which mirror the incredible diversity of scientific research. Take for instance the efforts to better understand secretion processes in yeast, the current research focus of Prof. Jeffrey Gerst and doctoral student Michael Marash of the Weizmann Institute's Molecular Genetics Department.
 
As it turns out, the study of yeast and other less-developed organisms holds the key to a better understanding of human cell secretion. In fact, the obvious differences between yeast, flies, and people dwindle unexpectedly when their mechanisms of secretion are closely observed.
 
Secretion, one of the most fundamental mechanisms of life, plays a central role in communication among living cells and is also involved in their construction and growth. Because the genes controlling this mechanism are well conserved in evolution, variations among species are relatively slight.
Gerst studies the genetic factors responsible for the cellular secretion of such substances as hormones and neurotransmitters. The secretion process begins with the formation, inside the cell, of a bubble containing the substance to be secreted. This bubble, or "vesicle," consists of a membrane of fatty molecules called phospholipids (the same molecules as those forming the cell membrane). When the secretion process is set in motion, it causes the vesicle to fuse with the cell membrane, resulting in the vesicle's contents spilling into the intercellular space (the space between cells). Vesicle-cell fusion is also an essential stage of cell growth: when the vesicle fuses with the membrane, the cell's surface grows, just as a quilt would expand if new patches were incorporated into its fabric.
 
How exactly does fusion between the vesicle and the cell membrane take place? Gerst, together with two other groups, found that this process is regulated by three proteins: Snc, Sso, and Sec9. Apparently, Sso and Sec9 are "irreplaceable" - when damaged, the secretion process is arrested and the cell dies. But more recently, Gerst has revealed that the third protein, Snc, has a "backup system." When this protein is damaged, genetic mutations in two other proteins (Vbm 1 and 2) may occur to restore cell growth and secretion. These mutations also have an interesting side effect - they lead to the cell's accumulation of precursors, called ceramides, required to build certain lipids.
 
The research team has now simulated this backup mechanism, leading to an important discovery - a "master switch" regulating secretion. When the scientists added ceramide precursors directly to the cells, the secreting cells continued to live and secrete properly even though one of the fusion factors was missing. The introduced material is, in effect, a sort of a chemical trigger that activates an enzyme, called a phosphatase, which breaks off a phosphorus-containing group of molecules from various proteins. The scientists established that this trigger operates not only in the backup system but also in Sso, one of the two "irreplaceable" fusion proteins.
 
Thus by identifying the "backup system" of one of the fusion proteins, Gerst and his team discovered the master switch. When one of the "irreplaceable" fusion proteins contains phosphorus, secretion is prevented; but when the phosphatase enzyme is activated and removes the phosphorus, the protein initiates membrane fusion, which in turn leads to secretion. The newly discovered role of this phospatase in secretion also shed s light on the enzyme's vital function in the growth of living cells.
 
A better understanding of these processes may lead to future ways of controlling the secretion process of various cells. For example, it may be possible to regulate the secretion of neurotransmitters by nerve cells, which could help treat degenerative brain diseases, or to control the secretion of hormones and other signaling chemicals, resulting in advanced cancer-treatments.
Prof. Jeffrey Gerst (left) and Michael Marash
Life Sciences
English

Physicist and Biologist Looking for Midwife

English

Amoebas help each other

 

Giving birth has never been easy. Nature seems to have decided that whoever wants to procreate should make an effort. Sometimes the process of birth, the physical separation from offspring, is so difficult that a mother needs a helping hand. And humans are not alone in this trait, as recently reported in Nature. An interdisciplinary research team at the Weizmann Institute has discovered that "midwives" also play a role in the microscopic world of amoebas. It is this collaborative birth process that has given amoebas an evolutionary edge.

 

Amoebas are single-celled organisms that reproduce asexually. Reproduction occurs when an amoeba doubles its genetic material, creates two nuclei, and starts to change in shape, forming a narrow "waist" at its middle. This process usually continues until the final separation into two cells. However, Weizmann Institute scientists found that in one type of amoeba this separation process stalls just before its completion. The two cells remain connected by a narrow tether, which they have difficulty severing using the normal cleavage mechanism. Until recently scientists envisioned only two possible scenarios at this fateful stage. In the first, the two cells, the "mother" and the "daughter," tug at their connecting tether, stretching it until it breaks and each can start a life of its own. In the second scenario, the two tug at the tether but fail to disconnect. After a while they give up and revert to being a single cell, which now has two nuclei.

A collaborative study by physicists and biologists at the Weizmann Institute has now revealed a third scenario, involving a "midwife" amoeba.

 

Prof. Elisha Moses of the Physics of Complex Systems Department had been studying the mechanical and physical aspects of how living cells separate. He discussed his work with Prof. David Mirelman, Dean of the Biochemistry Faculty, who, among other projects, investigates the properties of amoebas. Mirelman suggested that they examine how amoebas - which multiply faster than most other eukaryotic cells - separate.

 

The study took place in Moses' lab, which is equipped with sophisticated systems for observing and documenting the physical processes taking place at the level of a single cell. Much to their surprise the team found that in a significant number of cases, when the two amoebas have trouble disconnecting, a third amoeba rushes to their aid. This amoeba squeezes between them, exerting pressure until the "umbilical cord" snaps and each amoeba is free to go its own way.

 

The research team, which included graduate students David Biron, Pazit Libros, and Dror Sagi, went on to show that the struggling amoebas send out a chemical cry for help. When amoebas are placed in a culture flask and fluid is collected near the narrow "waist" of a dividing amoeba and subsequently released elsewhere in the flask, it causes other amoebas to flock to that spot - just like midwives responding to a call from a woman in labor. The phenomenon was even more pronounced when the scientists merely moved the tip of the pipette containing the attracting substance around in the flask, causing the amoebas to "chase" it.

 

The scientists believe that the chemical signal released by a dividing amoeba is a unique complex substance present in the amoeba's membrane, consisting of a lipid, a protein fragment, and some sugars. When an amoeba is trying to divide, the membrane in the area of its narrow "waist" stretches, undergoing enormous stress. This mechanical perturbation may cause the substance to be released into the nearby environment, thus "alerting" the "midwife" amoebas to come to the aid of the dividing amoeba.

 

The researchers plan to further investigate this phenomenon, in particular the precise composition of the attractant, its mechanism of release by amoebas undergoing division, and the nature of the "midwife's" receptor. This study may contribute to future attempts to control amoeba-borne infectious diseases, such as dysentery, through new therapies targeting amoeba reproduction.

Step by step documentation of "midwife"-assisted amoeba reproduction
Life Sciences
English

Shooting the Messenger

English

Careful actin regulation keeps the cell in shape

 
"Shoot the messenger" is apparently the name of the game in the body's protein regulation system. Researchers at the Weizmann Institute of Science have discovered that the synthesis and regulation of actin, the most abundant protein in human cells, is based on destroying its messenger RNA (mRNA). The messenger carries genetic information from the cell nucleus to actin-producing protein factories.

Actin serves as the central building block of the cytoskeletal fiber system that influences cell shape, division, adhesion, and motility. In turn, these cellular functions control important biological processes, including embryonic development and wound healing. To perform these functions, actin levels need to be balanced with clockwork precision. Indeed, faulty actin regulation can have wide-ranging, often devastating effects, including the onset of cancer and blood diseases.

Prof. Avri Ben-Ze'ev, along with Prof. Alexander Bershadsky and doctoral student Anna Lyubimova of the Weizmann Institute's Molecular Cell Biology Department, has recently zeroed in on one of the mechanisms regulating actin synthesis. Actin exists in the cell in two states: monomeric (or single unit) and polymeric (a chain of monomeric units). The researchers had previously found that a fine balance between these two forms regulates actin synthesis. When in excess, the monomeric actin destroys the mRNA machinery necessary for its own production.

Yet, how does actin actually regulate its own levels? Prof. Ben-Ze'ev and his team were able to pinpoint the precise region in the actin gene, which, when deleted, prevents the regulatory system from kicking in. They found that this regulation depends on a binding site activated when excess mRNA overflows into "unacceptable" parts of the cell. Deleting this region led to a dramatic increase in monomeric actin levels, coupled with severe aberrations in cell morphology.

Recently published in the Journal of Cellular Biochemistry, the Weizmann team's discovery of a direct link between regulating the genetic expression of actin mRNA and specific changes in cytoskeletal dynamics represents an important step forward in understanding the interplay between cell shape, structure, and gene expression.

Prof. Avri Ben-Zeev holds the Samuel Lunenfeld-Reuben Kunin Chair of Genetics.
 
Careful actin regulation keeps the cell in shape
Life Sciences
English

The Benefits of Immaturity

English
 
Prof. Michel Revel (right) and Prof. Tsvee Lapidot (left)
 

 

 

 

 

 

 

 

 

 
Weizmann Institute researchers have developed a molecule that allows blood stem cells -- the body's most primitive and most immature cells, which originate in the bone marrow -- to multiply without maturation in the test tube.
 
This achievement may improve bone marrow transplantation, in which stem cells are infused into a patient to replace defective or malignant marrow. The study may also advance gene therapy research.
 
The new molecule was developed by Prof. Michel Revel and Dr. Judith Chebath of the Molecular Genetics Department, and its effects on blood stem cells were studied by Dr. Tsvee Lapidot and graduate students Orit Kollet and Ronit Aviram of the Immunology Department.
 
Most stem cells originating in the bone marrow mature daily to replenish our blood. A small number of stem cells, however, survive and renew themselves without maturation, thanks to a natural mechanism in which the cells receive signals from molecules called cytokines. Among these molecules is interleukin-6, a chemical messenger discovered in the 1980s in Revel's laboratory. In order to respond to interleukin-6, the stem cells form a cluster with this cytokine, consisting of a receptor molecule on their surface known as gp130 and another molecule called the interleukin-6 receptor, which the cells pick up from surrounding fluids.
 
In contrast, when isolated in the test tube, the stem cells do not efficiently form the cluster with interleukin-6 and fail to survive: They start to mature into various types of blood cells and lose their original properties within three to five days. This has caused the greatest difficulty in studying stem cells and using them for therapeutic purposes
 
In their study, Weizmann Institute scientists used a so-called "chimera" recombinant molecule, consisting of interleukin-6 and its receptor fused together. The "chimera" proved extremely efficient in spurring on the formation of clusters with gp130 on the surface of stem cells purified from human bone marrow or from human umbilical cord blood. When the chimera was added to isolated stem cells together with other cytokines, the cells were able to survive in the test tube for two weeks and their numbers increased significantly. In the future, this new approach may make it possible to keep the stem cells proliferating without maturation for much longer periods.
 
By transplanting the treated human stem cells into mice with severe combined immunodeficency, the scientists verified their ability to repopulate the bone marrow and produce all types of blood cells, demonstrating that the stem cells had indeed remained immature. A large increase in the efficacy of transplantation was observed with the stem cells that had received the chimera treatment compared with untreated cells.
 
If the Weizmann Institute molecule is adopted for clinical use, allowing stem cells to survive longer and increasing their numbers, the success of bone marrow transplantation can be improved. Such transplantation is currently used to treat an increasing number of diseases, including different types of leukemia and cancerous tumors, several blood cell disorders and even autoimmune diseases such as multiple sclerosis.
chimera Interleukin-6 molecule
 
The Institute study may also provide a boost to gene therapy research by giving scientists a larger window of opportunity for inserting genes into human stem cells maintained in the laboratory. If scientists manage to do that, they may be able to develop gene therapy for various genetic disorders such as thalassemia, severe combined immuno?deficiency, Gaucher's disease, and other disorders. Since transplanted stem cells repopulate the bone marrow of the recipient and daily produce billions of blood cells, inserting a gene in these cells prior to transplantation would ensure a steady supply of the protein made by this gene, compensating for the genetic defect causing the disease.
 
The Institute scientists collaborated with researchers from the Bone Marrow Transplantation Center at the Hadassah University Hospital in Jerusalem, from the Kaplan Hospital in Rehovot and from the Jackson Laboratory, Bar Harbor, Maine.
 
Life Sciences
English

Death of a Protein

English
 
Prof. Moshe Oren: Protecting cancer suppressors
 

 

 

 

 

 

 

 

 

For the proteins in our body there's not much room for mercy. If old or damaged proteins were allowed to accumulate in a cell, it would soon become useless. Thus, a sophisticated recycling system quickly breaks down deficient proteins. But, as has recently been found, healthy proteins, including proteins that inhibit cancer, often meet the same fate. This is due to a molecule that, together with its helpers, serves as a "death tag." Weizmann Institute scientists have identified one of the sinister helpers involved in the nefarious work of breaking down cancer-preventing proteins.
 
Twenty years ago, Profs. Abraham Hershko and Aharon Ciechanover of the Technion Medical School discovered an enzyme system dedicated to breaking down proteins in the cell. This system contains many kinds of enzymes, each responsible for seeking out and destroying a specific group of proteins, according to their three-dimensional structure. The scientists discovered the existence of a small protein called ubiquitin, which functions as a sort of "death tag." Ubiquitin is attached to the damaged protein by enzymes, and it then "calls out" to the various wrecking enzymes. After these complete their work, the "death tag" is released and returns to a cache in the cell.
 
It has recently come to light that the same system is also responsible for breaking down functioning proteins when their level rises above that desired in the cell. Prof. Moshe Oren of the Weizmann Institute's Molecular Cell Biology Department is studying the p53 protein, product of the p53 gene, whose proper functioning inhibits the development of tumors. Apparently over 50% of cancers in humans are caused by changes in the p53 gene that lead to the protein's dysfunction. In normal cells the amount of p53 protein is minute; but the moment the cell is exposed to a process that may lead to mutation and thence to the development of cancer, the amount and activity of the p53 protein increases rapidly. As a result, the cell ceases to divide until the damage is repaired. In those cases where the damage is impossible to repair, the p53 protein instructs the cells to self-destruct so that the organism as a whole may live. In either case the p53 protein prevents the malignancy from evolving.
 
In normal cells, where the risk of malignancy is nonexistent, the ubiquitin system is responsible for the rapid breakdown of the p53 protein, preventing its accumulation in amounts that could disrupt the cell's normal operation. When the cell is "spoiled" in a way that may cause it to become cancerous, p53 is called into action and accumulates rapidly. The key to its accumulation is a disguise designed to help it evade the ubiquitin system. "Today we know that exposing cells to DNA damage causes the addition of phosphate molecules to the p53 molecule," says Oren. "These changes prevent identification of the protein by the ubiquitin system, and 'rescue' it." Oren and his team have recently begun to focus on defining the biochemical processes that oversee each of the phosphate sites and finding the mechanism by which phosphate affects the ability of the ubiquitin system to recognize the p53 protein.
 
They have discovered that a second protein, called Mdm2, is responsible for attaching ubiquitin, the "death tag," to the p53 protein. Thus Mdm2 is a critical factor involved in regulating the levels of the p53 protein in the cell. "According to recent information, some of it acquired in our lab, it seems that the rate at which p53 is broken down may be altered not only by changes caused by phosphates, but also by variations in the concentration and activity of Mdm2 in the cell," says Oren.
 
Red: Nucleii containing p53. Green: Nucleii genetically engineered to express Mdm2. In these cells, p53 does not accumulate because it is broken down by the ubiquitin system.
 
p53 fulfills a major role in the processes that affect the accretion, or nonaccretion, of genetic mutations that may lead to the development of cancer. "The cells have developed complicated warning systems, each of which can delay the breakdown of p53, thus preventing cancerous processes," says Oren. "If we can understand how the breakdown of p53 is modulated, we can intervene in this process using medication and boost mechanisms that protect from cancer."
As a result of Oren's research, drugs that cause increased p53 activity in cancerous cells by interfering with its breakdown via Mdm2 are being developed by several drug companies, in an attempt to arrest proliferation and even induce tumor remission.
 
Life Sciences
English

The Pearling Effect

English

From left to right: Prof. Samuel Safran, Dr. Alexander Bershadsky and Prof. Elisha Moses

A highlighted sentence in a book on the desk of Prof. Elisha Moses reads: "When the real world is recalcitrant, we build ourselves toy models in which the equations are simple enough for us to solve." Accordingly, Moses built a simplified model of a cell -- similar to a soap bubble but one-thousandth of a millimeter in size. Using this model, he has found out that cells can be tickled to "tears."
 
Moses, of the Physics of Complex Systems Department, agitates artificial cell membranes with laser tweezers (used for "grabbing" microscopic targets and moving them around). Along with Ph.D. student Roy Bar-Ziv, he found that pulling on membranes causes them to break into droplets reminiscent of a trail of tears or a string of pearls. Since cell shape is related to function, this finding is of great interest to biologists. So Dr. Alexander Bershadsky of the Molecular Cell Biology Department joined the research effort. Their aim: to find out if the "pearling" effect was present in live cell membranes as well.
 
And sure enough, Bershadsky was able to induce this effect in live cells through the use of a drug that virtually knocks out the structure inside the cell just below the membrane, called the cytoskeleton. Proof that the pearling effect also exists in live cells has lent additional weight to the research. Since weakening of the rigidity of the cytoskeleton is a characteristic of cancer cells, knowing the effect of this trait on membrane shape -- and how drugs control membrane shape -- may provide new clues to the development of cancer.
 
An almost inconceivable research trio came into being when theoretical physicist Prof. Samuel Safran of the Materials and Interfaces Department joined the team. For those not familiar with the scientific spectrum, biology and theoretical physics are considered to be at opposite ends. Very seldom does one find a biologist working alongside a theoretical physicist. "Biologists and physicists speak different languages. Our first objective was to find a common one. This study shows that we succeeded," says Safran.
 
Safran's research group constructed a theory that successfully predicts how the shape of the membrane will vary with cytoskeleton rigidity, and hence with the concentration of the drug. Says Safran: "The ability to predict is a major step toward the ability to control."
 
In addition, Moses is currently involved in another study combining physics and biology; he is investigating how neurons branch out and connect to one another. Neurons, which form a network through which they send electrical currents to one another, may be the key to constructing biological computer chips to replace or improve silicon chips in the future. Here the physicist must use his understanding of organization, connectivity and cooperation in many body systems to try to decipher the cell's innate ability to construct electrical circuits.
 
"This isn't the physics of the Big Bang," says Moses. "It's physics on a human scale, the physics of people."
Life Sciences
English

Cell Peer Pressure

English
An outdoor discussion. From left to right: Prof. Lia Addadi, Ph.D. student Ella Zimmerman and Prof. Benjamin Geiger

"Tell me who a cell's neighbors are, and I'll tell you how it looks and behaves," says Prof. Benjamin Geiger, head of the Molecular Cell Biology Department. Together with biologists, chemists and physicists at the Weizmann Institute, he is observing the adhesion of cells in order to find clues to how they transfer information -- or don't.

 
Cells communicate -- at times by touch, at times by sending messages. And as in so many other situations in life, when communication is severed, crisis is born. In the body, one such crisis is cancer. When scientists interfere with a cell's physical contact with its neighbor, i.e., interfere with "touch" communication, the cell's appearance and behavior change. "Cells are like members in a society -- each has its role, communicated to it by other cells and dependent on them," says Geiger.
 
Through observation of cell adhesion, the uncontrolled proliferation of cells characteristic of cancer may be understood. Under normal conditions, when cells reach a certain density they stop multiplying. In recent studies, Geiger showed that the physical contact between cells generates signals instructing cells to stop multiplying. "We are now trying to find the molecular mechanism of this communication system," says Geiger. "The failure of this proliferation control mechanism might be a cause of malignant tumor formation."
 
Another question critical to cancer research that involves adhesion: How does a tumor dissociate itself from surrounding cells and move elsewhere in the most dangerous of stages in cancer, metastasis (the condition in which the malignancy spreads to other organs in the body)?
 
"Since so little is known about cell-to-cell adhesion, we felt that we must first analyze the cell's adhesiveness to a known and defined surface. And what is better defined and understood than a crystal?"
 
This is where Prof. Lia Addadi, head of the Structural Biology Department, came in. Joining her expertise in crystal behavior and Geiger's knowledge of cell behavior, they observed the way in which cells bind to different crystal surfaces. They found not only that cell adhesion was dependent on the chemical structure of the crystal, but also that cells were incredibly picky and specific as to what they would bind to. For instance, cells would stick to a crystal of a certain chemical composition but would not stick to the surface of its mirror image.
 
Cells under the microscope
 
To study the mechanical properties of cell adhesion, Dr. Michael Elbaum came on board. A physicist in the Materials and Interfaces Department, Elbaum is analyzing questions that require a thorough understanding of mechanics: How much force is needed to tear a cell away from a surface? How does this change from surface to surface? In short, how much of a fight can a cell put up? The answers to these questions are important for the understanding of metastasis.
 
Elbaum is testing this by conducting a "contest" between cells and powerful focused laser beams that can hold them in place. The studies are being carried out in collaboration with Dr. Alexander Bershadsky of the Molecular Cell Biology Department, who is an expert in the force-generating machinery of cells just below the cell membrane, a system known as the cytoskeleton.
 
Yet another angle to the understanding of cellular adhesion was provided by Prof. Zvi Kam, also of the Molecular Cell Biology Department, who masterminded a high-resolution digital microscope for the study. The novel microscope system, made possible by Kam's knowledge of optics and advanced image processing, has proven pivotal in detecting and quantifying molecules active in cell adhesion. The system is used to observe how these molecules spread throughout cells, relaying messages from their surroundings.
 
With biologists, chemists and physicists each contributing their pieces to the puzzle, there is hope that more comprehensive answers will be found to the many unknowns of cell adhesion. "The boundaries between the traditional research disciplines have become blurred," says Geiger. "Biology, chemistry and physics are each bringing something of their own to the table, contributing in concert to the unraveling of the mysteries of cell adhesion."
 
Life Sciences
English

Bubble, Bubble, Toil and DNA Damage

English

Prof. Amos Breskin and Dr. Rachel Chechik

When you have an X-ray, what happens to your DNA? When a cancer patient undergoes radiation treatments, how much is too much?


The precise answers to these questions may dwell inside a tiny gas bubble.

Damage to DNA is believed to be the major cause of cell mutation and in some instances, death. A group of physicists whose work overlaps the realm of biology, headed by Professor Amos Breskin of the Particle Physics Department, got to thinking: Just how do you analyze radiation's effects on something as small as DNA if no particle detector has the sensitivity to determine it?

Possible answer: If the DNA were in gaseous form, it would then be considerably expanded in size and thus easier to determine change. And that is how the tiny gas bubble was born. A simulated fragment of DNA in gaseous form, it's only a millimeter in size ­ but one million times the size of our DNA.

Prof. Amos Breskin, together with departmental colleagues Drs. Rachel Chechik and Sergei Shchelmelinin, have succeeded in constructing the first detector that permits measuring the effects of radiation on a DNA-like gas bubble.

Prior to this, scientists throughout the world had constructed gas models of cells and chromosomes. But because cells and chromosomes are much larger than DNA, those models could not predict potential damage to the diminutive DNA. The new particle detector, 100 to 1,000 times more precise than prevailing techniques, could fulfill the task.

How does the detector work? When radiation penetrates the cell, it breaks molecular bonds in the DNA. Each molecule then separates into an electron (negatively charged) and an ion (in this case, positively charged). This means that the more electrons and ions spotted in a cell, the more bonds have been broken.

The question is, have the DNA double strands both broken too? Once you detect a large concentration of particles in the DNA-like gas bubble, and with it proof that many bonds could have been broken at one particular site, you may have found what you were looking for ­ an irreparable break in the DNA double strands.

Causing these electrons or ions to fly out of the bubble, Prof. Breskin can count them using the new detector. The ion rate of release is a telling indicator of the frequency of reactions which went on between the radiation and the gas and their concentration in the vicinity of the DNA strand. The scientists can then use scaling factors to predict the frequency of interactions in the actual smaller, solid volume of DNA.
 
The same X-ray or particle beam that enters the bubble, exits it and interacts with a sample of living cells. The cells' rate of destruction is compared with the radiation effect on the DNA gas model. The researchers intend to determine the direct correlation between the radiation dose causing potential, permanent damage to DNA, and cell destruction.

Once the researchers have found the details of the correlation between the two experiments, it will pave the way for more accurate predictions of radiation effects on the living cell.
In treating cancer, the object is to destroy the DNA in tumor cells using as little radiation as possible, so as not to damage the surrounding healthy tissue. "Once you know how much radiation breaks DNA strands, you can better determine how much radiation to expose cancer patients to," says Professor Breskin.

Along with its potential impact on cancer screening and treatment, Prof. Breskin's approach may make safer our personal health by allowing scientists to designate more precise limits on the number of X-rays a person may undergo yearly, including those we are exposed to at the dentist's office and during a routine mammography. Better informed standards on radiation exposure in the workplace could be set.

Breskin's group's research may even affect space programs, clarifying radiation's impact on astronauts. It could lead to new approaches on how best to protect advanced electronic equipment in satellites and other space objects from cosmic radiation.

All of this, thanks to Breskin's little gas bubble.
 
Life Sciences
English

Pages